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Smoking, Epidemiology and E-Cigarettes 
 
“The true face of smoking is disease, death and horror - not the 
glamour and sophistication the pushers in the tobacco industry try to 
portray.” - David Byrne  
 
In our fellows’ conference we recently reviewed the evolution of the 
science of clinical epidemiology as it relates to the association of 
smoking and lung cancer and the concurrent history of tobacco 
marketing in the United States.   
 
This story begins in 1950, when Richard Doll and Austin Bradford Hill 
published their landmark case control study demonstrating the 
association between smoking and lung cancer (1). This study was 
performed with methodological standards that have rarely been 
matched in the 63 years since.  Exhaustive analysis of possible 
confounders, a multi-stage evaluation of study blinding, determination 
of dose-effect, and the use of multiple analyses to establish 
consistency are among many examples of superb attention to detail 
exercised by Doll and Hill in this study.  The results showed that 
patients with lung cancer were about 15 times more likely than 
matched control patients to have smoked tobacco (Odds ratio 15).  
The p-value was 0.00000064  - indicating that the probability of 
calculating such a result by chance alone is less than one-in-a-million.  
In comparison, many modern case control trials are characterized by 
weak associations (odds ratios of 1-3) with p-values that are barely 
significant.  Yet the phenomenal and nearly unparalleled results of this 
study had practically no discernable effect on the increasing rate of 
smoking in the following decade. 
 
Many factors opposed the conclusions of Doll and Hill.  Atmospheric 
pollution – perhaps emanating from motor car exhaust or asphalt 
tarmac – was felt to be the leading suspect in the increasing incidence 
of lung cancer.  At the time, it seemed inconceivable to most people 
that smoking could cause cancer.  Two thirds of British men smoked.  
Smoking was widely endorsed by the medical profession – Doll and Hill 
themselves had both previously been smokers.  The British 
Department of Health did not endorse their findings, amid worries that 
the study might start a panic.  Several prominent statisticians, 
including Sir Ronald Fisher, publicly criticized their study design and 
conclusions.  Fisher was a polymath – a genius with significant 
accomplishments in multiple disciplines, widely recognized as the 
founder of modern statistics, having invented Fisher’s exact test, and 
ANOVA and having collaborated in the development of the Student’s T 
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Fisher had lucrative financial ties to the tobacco industry, raising 
questions whether Fisher’s criticisms of Doll and Hill were bought and 
paid for. 
 
Doll and Hill followed up with a stronger study design – performing one 
of the finest cohort studies ever – the British Physician’s study.  They 
enrolled over 40,000 British Physicians – almost 70% of all registered 
in Britain.  Outcomes in this cohort were eventually evaluated over 50 
years, and contributed to our knowledge in many areas of medicine.  
But the results in regards to the relationship between smoking and 
lung cancer were objectively convincing within the first decade of 
follow-up.  In an interim analysis in 1961 (2), the relative risk for lung 
cancer in smokers was found to be increased 18 times – consistent 
with the findings of their case control trial.  Fisher’s exact test was 
incalculable in 1961 since it required the quantization of enormous 
factorials, but I calculated a p-value of 0.0000000000000001 (one in 
100-quadrillion) using their data and an on-line Microsoft statistics 
program.  It’s satisfying to find that Fisher’s namesake statistic so 
convincingly validates the conclusions that he personally refuted.  Sir 
Austin Bradford Hill is famous for his contention that we often over-
focus on achieving a p-value < 0.05 in modern medical research – the 
incomparable statistical significance of this study illustrates his point.   
 
Despite increasing scientific evidence against smoking, cigarette 
consumption in the U.S. continued to rise, and did not fall below pre-
1950 levels until the early eighties.  A further generation of young men 
took on the habit, many of which were introduced to smoking in the 
armed services - cigarettes having been routinely included in C-rations 
of US soldiers who fought in WWII, Korea and Viet Nam.  Cigarette 
smoking was endorsed by everyone from movie stars, to sports stars 
to doctors – Bob Hope, Mickey Mantle and Ronald Reagan among 
them.  Santa Claus appeared in multiple ads with a cigarette in one 
hand, and his red toy bag in the other – fecklessly endorsing multiple 
different brands including Lucky Strikes and Pall Malls.   
 
Several tobacco advertisement campaigns were particularly influential.  
Philip Morris introduced the “Marlboro Man”, considered one of the 
most brilliant ad campaigns in history, in 1954.  Marlboro cigarettes 
were filtered.  The implied (but factitious) protective benefits of the 
filter were not explicitly marketed, but filtered cigarettes were 
considered “feminine” at the time.  The use of real rodeo cowboys in 
the Marlboro ads dramatically changed that impression – particularly in 
the minds of post adolescent boys.  One indication of the success of 
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million dollars finding a replacement when Darrell Winfield, the most 
famous of the Marlboro men, retired. 
 
In the late sixties, Philip Morris also marketed smoking to young 
women with a brand designed specifically for women called Virginia 
Slims.  Riding the wave of women’s liberation, the slogan “You’ve 
come a long way baby” promoted smoking as a way to express 
emancipation and empowerment.   RJ Reynolds introduced the “Joe 
Camel” ad campaign in 1987, allegedly targeting children with a cool-
looking cartoon of an anthropomorphic camel.  Sounds silly, I know, 
but it worked.  In 5 short years after starting this campaign, the 
annual sales of Camel cigarettes to teenagers rose from 6 million to 
470 million dollars.  At its peak, it was shown that six-year-old 
children could associate the character of “Joe Camel” with Camel 
cigarettes about as frequently as they could associate Mickey Mouse 
with Disney.  A study published in JAMA concluded that tobacco 
experimentation by 700,000 adolescents per year could be attributed 
to targeted advertising (3).   
 
Although public education had already made great inroads in reducing 
smoking in the US by the 80’s, legal and governmental anti-smoking 
pressure began to build thereafter.  In 1988, Rose Cipollone  
posthumously won the first successful wrongful harm lawsuit of a 
smoker against a tobacco manufacturer.  Mangini sued RJ Reynolds on 
behalf of children in regards to the Joe Camel ad campaign.  In the 
1988 Report of the Surgeon General, C Everett Koop concluded that 
nicotine has an addictiveness similar to that of heroin.  C Everett 
Koop’s continuing efforts to raise public awareness initiated some of 
the first public discourse in regards to the dangers of second-hand 
smoke (subsequently found to cause 50,000 deaths per year in the 
U.S.).  Smoking rates in the United States declined from 38% to 27% 
during his tenure.  
 
In the 1990s, the tobacco lobby engaged in a comprehensive and 
aggressive political effort to neutralize clean indoor air legislation, 
minimize tobacco tax increases, and preserve the industry's marketing 
strategies.  However the famous Waxman congressional hearings 
intervened in 1997.  In sworn testimony before congress, the CEOs of 
seven major tobacco companies famously asserted that smoking 
tobacco was not addictive, contrary to incontrovertible scientific 
evidence.  Two sources revealed their insincerity.  The first was 
testimony of previous employees of the tobacco industry, such as 
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and carcinogenic properties of cigarette tobacco had been artificially 
manipulated by the industry.   The second was the discovery of 
internal tobacco industry memos, which revealed that the addictive 
properties of tobacco were well recognized within the industry as early 
as 1960s.  A few excerpts follow:  
“… nicotine is addictive. We are, then, in the business of selling 
nicotine, an addictive drug” July 17, 1963 report by then Brown & 
Williamson general counsel/vice president Addison Yeaman. 
 “The cigarette should be conceived not as a product but as a package. 
The product is nicotine. …Think of a cigarette as a dispenser for a dose 
unit of nicotine…”  1972 William Dunn, Jr., of the Philip Morris 
Research Center, “Motives and Incentives in Cigarette Smoking.” 
“Within 10 seconds of starting to smoke, nicotine is available in the brain. . . 
giving an instantaneous catch or hit . . . Other “drugs” such as marijuana, 
amphetamines, and alcohol are slower”  Circa 1980  C.C. Greig in a BAT R&D 
memo 
 
The Waxman hearings resulted in a $368 billion dollar assessment 
against the tobacco industry, and increased restrictions on advertising 
and lobbying.  Shortly thereafter, the Joe Camel and Marlboro Man ad 
campaigns were terminated.  With the public revelation that three 
previous Marlboro Men had died from lung cancer, that ad campaign 
had lost its appeal.    
 
In the late 90s/early 2000s, the nicotine content of all major brands of 
cigarettes was progressively increased on average by 1.8% per year.  
This might theoretically make it harder for smokers to kick the habit.  
Sales promotions totaling about $400 per year per smoker were 
directed at loyal smokers.  Despite restrictions, the tobacco industry 
continued to invest $25 million dollars per year in lobbying.  Upon 
further negotiation, the tobacco master settlement was reduced to 200 
billion – only 12.7 billion to be paid up front.  The full details of this 
settlement have become increasingly legally obfuscated over time in 
my opinion; some states are actually selling tobacco settlement bonds 
now to protect themselves against loss of future return from the 
settlement.     
 
Although US cigarette consumption has dramatically fallen, worldwide 
sales are peaking, and the international rates of women smokers are 
still on the rise.  Philips Morris restructured and rebranded their 
corporation as Altria (sounds like the word “altruistic”).  They 
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subsumed Kraft and Nabisco foods, but the majority of their >100,000 
million dollars in annual revenue are derived from tobacco sales, about 
two-thirds of which are international.   
 
Many US tobacco firms are rapidly investing in production and 
marketing of electronic cigarettes that vaporize nicotine for inhalation.  
It is likely that inhaling vaporized nicotine is less dangerous than 
smoking tobacco.  However, the health effects of inhaling vaporized 
nicotine are not well studied yet.  The purported benefits of vaping 
over smoking have already been publicly aired as an argument to turn 
back current restrictions on public smoking.  Electronic cigarettes are 
being advertised as glamorous again in advertisements reminiscent of 
tobacco ads seen in the 1970s.  E-cigs in which nicotine is flavored 
with chocolate, or various fruit flavors, seem to once-again target 
children.  The promotion of a highly addictive drug to children and 
young adults cannot be beneficial to society in the long term, even if 
vaping doesn’t lead to lung cancer.  But the rapid increase in vaping 
promises that another round in the societal struggle against nicotine 
addiction is about to begin again. 
 
Doll and Hill’s work played a tremendous beneficial role in this story.  
Their case control and cohort studies set the methodological standard 
by which all subsequent observational trials should be measured – 
although our experience in journal club is that modern observational 
trials don’t even come close.  Furthermore, their work became the 
basis for the subsequent formulation of the “Bradford Hill Criteria” for 
establishing causation, which still plays a dominant role in medical and 
medicolegal reasoning.    
 
Robert A. Raschke, MD 
Associate Editor 
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